pcDNA3-SARS-1-RBD-8h
(Plasmid
#161821)
-
PurposeMammalian expression plasmid for RBD of SARS-CoV-1 (Urbani strain)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 161821 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1(+)
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5332
- Total vector size (bp) 6034
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameReceptor-binding domain (RBD) of spike protein S
-
Alt nameRBD
-
SpeciesSARS coronavirus 1 (Urbani isolate)
-
Insert Size (bp)702
-
MutationHuman codon optimized RBD (a.a. T320-D518)
-
GenBank IDAAP13441.1
- Promoter CMV
-
Tags
/ Fusion Proteins
- GSG linker and 8his tag (C terminal on insert)
- HA leader sequence (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer CMV-fwd
- 3′ sequencing primer BGH-rev (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3-SARS-1-RBD-8h was a gift from Erik Procko (Addgene plasmid # 161821 ; http://n2t.net/addgene:161821 ; RRID:Addgene_161821) -
For your References section:
An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants. Chan KK, Tan TJC, Narayanan KK, Procko E. Sci Adv. 2021 Feb 17;7(8). pii: 7/8/eabf1738. doi: 10.1126/sciadv.abf1738. Print 2021 Feb. 10.1126/sciadv.abf1738 PubMed 33597251